 SAN CARLOS, Calif., Aug. 09, 2022 GLOBE NEWSWIRE -- ChemoCentryx, Inc., Nasdaq: CCXI, today announced the cancellation of its second quarter 2022 financial results conference call scheduled for Tuesday, August 9, 2022, at 5:00 p.m. ET. The call is being cancelled due to the August 4, 2022, announcement that Amgen and ChemoCentryx, Inc. signed a definitive agreement pursuant to which Amgen would acquire ChemoCentryx. 